2-hydroxy Myristic Acid

CAS No. 2507-55-3

2-hydroxy Myristic Acid( —— )

Catalog No. M35033 CAS No. 2507-55-3

2-hydroxy Myristic Acid is a hydroxy fatty acid with antiviral activity Inhibits enteroviruses .2-hydroxy Myristic Acid can be used to study viral infections.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 49 In Stock
10MG 81 In Stock
25MG 128 In Stock
50MG 182 In Stock
100MG 267 In Stock
500MG 669 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    2-hydroxy Myristic Acid
  • Note
    Research use only, not for human use.
  • Brief Description
    2-hydroxy Myristic Acid is a hydroxy fatty acid with antiviral activity Inhibits enteroviruses .2-hydroxy Myristic Acid can be used to study viral infections.
  • Description
    2-hydroxy Myristic Acid is a hydroxy fatty acid with antiviral activity Inhibits enteroviruses .2-hydroxy Myristic Acid can be used to study viral infections.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    Antiviral
  • Recptor
    Antiviral
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2507-55-3
  • Formula Weight
    244.37
  • Molecular Formula
    C14H28O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(O)C(O)CCCCCCCCCCCC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Moroxydine hydrochlo...

    Moroxydine hydrochloride is a synthetic antiviral drug chemically belonging to the series of the heterocyclic biguanidines. Structurally moroxydine is a heterocyclic biguanidine.

  • DDG-39

    DDG-39 (1-(2,3-dideoxy-2-fluoropentofuranosyl)cytosine) possesses antiviral activity with potent and selective anti-HIV-1 and HBV activity in cell culture. The average antiviral IC50 is 0.61 μM.

  • DO-IN-2

    IDO-IN-2 is an IDO inhibitor extracted from patent WO/2015031295 A1, compound example 1.